HEALTHABC NEWS
FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list
An FDA advisory committee voted to add the popular peptide BPC-157 to a drug compounding list. The decision was made on Thursday, as stated in the article.
Related Signal
Adjacent reporting
- FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
- The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.
- FDA panel narrowly backs unapproved peptide drug touted by Joe Rogan and other influencers
- FDA panel considers easing peptide restrictions